Risk-Adapted Empiric Therapy for Acute Cholangitis: Beyond the Broad- Versus Narrow-Spectrum Dichotomy
Cureus · 26.06.2026
DOI: 10.7759/cureus.111582 ↗Kurz gefasst
Editorial in der Zeitschrift Cureus, erschienen am 26.06.2026. Verfasst von Sakue Masuda und 4 weiteren Autor:innen. Beteiligte Einrichtung: Gastroenterology Medicine Center, Shonan Kamakura General Hospital, Kamakura, JPN. Die Arbeit nennt 5 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Gastroenterology Medicine Center, Shonan Kamakura General Hospital, Kamakura, JPN.
- Cancer Care Promotion Center, University of Fukui Hospital, Eiheiji, JPN.
Zitieren
APA
Masuda, S., Imamura, Y., Kimura, K., Makazu, M., & Koizumi, K. (2026). Risk-Adapted Empiric Therapy for Acute Cholangitis: Beyond the Broad- Versus Narrow-Spectrum Dichotomy. Cureus. https://doi.org/10.7759/cureus.111582
Vancouver
Masuda S, Imamura Y, Kimura K, Makazu M, Koizumi K. Risk-Adapted Empiric Therapy for Acute Cholangitis: Beyond the Broad- Versus Narrow-Spectrum Dichotomy. Cureus. 2026. doi:10.7759/cureus.111582
BibTeX
@article{Masuda2026,
author = {Masuda, Sakue and Imamura, Yoshinori and Kimura, Karen and Makazu, Makomo and Koizumi, Kazuya},
title = {Risk-Adapted Empiric Therapy for Acute Cholangitis: Beyond the Broad- Versus Narrow-Spectrum Dichotomy},
journal = {Cureus},
year = {2026},
doi = {10.7759/cureus.111582}
}
EUVIMED